๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers

โœ Scribed by S. -M. Huang; T. B. Marriott; H. S. Weintraub; J. D. Arnold; J. Boccagno; R. Abels; W. Harris

Publisher
Springer
Year
1988
Tongue
English
Weight
394 KB
Volume
34
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Single dose pharmacokinetics of sumatrip
Single dose pharmacokinetics of sumatriptan in healthy volunteers
โœ L. F. Lacey; E. K. Hussey; P. A. Fowler ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 516 KB

Sumatriptan is classified as a vascular 5HT 1 receptor agonist and is effective in the acute treatment of migraine and cluster headache. Sumatriptan is available as an injection for subcutaneous administration and as a tablet for oral administration. The pharmacokinetics of sumatriptan differ depend

Single dose pharmacokinetics and bioavai
Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers
โœ Michael J. Lamson; John P. Sabo; Thomas R. Macgregor; Joseph W. Pav; Lois Rowlan ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB ๐Ÿ‘ 2 views

The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.

Single and multiple dose pharmacokinetic
Single and multiple dose pharmacokinetics of etizolam in healthy subjects
โœ C. Fracasso; S. Confalonieri; S. Garattini; S. Caccia ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 498 KB

The pharmacokinetics of etizolam, a new thienodiazepine derivative, has been examined after single and multiple (0.5 mg tablet) (0.5 mg b.d for 1 week) oral therapeutic doses in healthy volunteers. The single-dose kinetic profile of etizolam suggested that absorption after oral dosage was reasonably

The single dose pharmacokinetics and saf
The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers
โœ Harri Kanerva; Olavi Kilkku; Esa Heinonen; Antti Helminen; Juha Rouru; Simo Tarp ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 201 KB ๐Ÿ‘ 2 views

The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg